Metraipolis › archive › dc_a80b30732ddc

Efficacy of Intravitreal Brolucizumab for Chronic Central Serous Chorioretinopathy: A Pilot Study — Europe PMC PMID:41003112

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41003112
DOI
10.3390/jpm15090409
License (as archived)
solo-consultazione
Archived
2026-11-10T04:22:23.194Z
SHA-256 of the archived text
7a08e9b3cde41862521d3d41e84f85d86f008e3d64eb3fdfef3e6e10d0a0fab6
Stable URL of this page
https://metraipolis.com/documento/dc_a80b30732ddc

How to cite

Efficacy of Intravitreal Brolucizumab for Chronic Central Serous Chorioretinopathy: A Pilot Study — Europe PMC PMID:41003112 — Europe PMC (en), https://europepmc.org/article/MED/41003112 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a80b30732ddc (Metraipolis archive dc_a80b30732ddc, sha256 7a08e9b3cde41862521d3d41e84f85d86f008e3d64eb3fdfef3e6e10d0a0fab6)
BibTeX
@misc{dca80b30732ddc,
  title = {Efficacy of Intravitreal Brolucizumab for Chronic Central Serous Chorioretinopathy: A Pilot Study — Europe PMC PMID:41003112},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41003112},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a80b30732ddc; sha256 7a08e9b3cde41862521d3d41e84f85d86f008e3d64eb3fdfef3e6e10d0a0fab6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41003112. Agents can read the archived copy with the MCP tool read_document.